BioSpace News Archive

Researchers present findings at EASL International Liver Congress™ 2021, June 23-26, 2021.

Vericel Corporation today announced that Nick Colangelo, President and CEO, will present the latest company overview at the Goldman Sachs 42 nd Annual Global Healthcare Conference.

DURECT Corporation (Nasdaq: DRRX) today announced it will present two posters at the 2021 International Liver Conference (EASL) to be held virtually June 23-26 , 2021.

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced the appointment of Brent Dial, MBA, as Chief Financial Officer.

Qosina, a global supplier of OEM single-use components to the medical and bioprocess industries, has expanded their Class VI tubing portfolio to include 50 new products

iTolerance, Inc today announced the formation of its Executive Leadership Team with the hiring of Anthony Japour, M.D. as Chief Executive Officer and Camillo Ricordi, M.D. as Chief Scientist.

Revelation Biosciences Inc. (Revelation), a clinical stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today that James Rolke, Revelation’s Chief Executive Officer, will present a corporate overview at the BIO Digital Conference.

The report highlights trends prevailing in the global bioactive wound management market and the factors driving market along with those that act as hindrances.

The contraceptives market is expected to reach US$ 29,629.4 million in 2028 from US$ 20,825.0 million in 2020; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028.

The market is estimated to grow with a CAGR of 3.8% from 2019-2027.